Pooled results from phase 3 clinical trials demonstrate that roxadustat is efficacious and may be comparable to placebo in studies done to date for treating anemia in patients with chronic kidney disease who do not require dialysis.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/08/210806171916.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/08/210806171916.htm
Trials reveal efficacy and safety of oral drug for treating anemia associated with kidney disease
Reviewed by cmakigo
on
August 07, 2021
Rating:
No comments:
Post a Comment